Additional file 6: Table S6. of Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
收藏数据链接:
官方服务:
资源简介:
Ingenuity Pathway Analysis. (XLSX 115Â kb)
创建时间:
2016-12-14

Ingenuity Pathway Analysis. (XLSX 115Â kb)